DiscoverThe Genetics PodcastPrecision Pioneers EP 2 - Aristea Therapeutics CMO Nihar Bhakta on developing precision medicines for both common and rare diseases
Precision Pioneers EP 2 - Aristea Therapeutics CMO Nihar Bhakta on developing precision medicines for both common and rare diseases

Precision Pioneers EP 2 - Aristea Therapeutics CMO Nihar Bhakta on developing precision medicines for both common and rare diseases

Update: 2021-03-25
Share

Description

This week Patrick talks to Nihar Bhakta as part of our series of ‘Precision Pioneers’. Dr Bhakta is the Chief Medical Officer at Aristea Therapeutics, a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. Dr Bhakta specialises in precision medicine and in this episode they focus on his work developing precision medicines for both common and rare diseases.



This is the second episode in a mini-series on ‘Precision Pioneers’ - stay tuned for more episodes in this area and find previous episodes by searching for The Genetics Podcast on any podcast provider.

Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Precision Pioneers EP 2 - Aristea Therapeutics CMO Nihar Bhakta on developing precision medicines for both common and rare diseases

Precision Pioneers EP 2 - Aristea Therapeutics CMO Nihar Bhakta on developing precision medicines for both common and rare diseases

Sano Genetics